European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn:
“ESTRO24 Highlights in radiobiology and SBRT:
- Isotoxic doses in pancreatic cancer
- Genetic insights into breast cancer radioresistance
- STAT3 inhibition for brain metastases radionecrosis
- Synergy of radiotherapy and immunotherapy
- Hypofractionation benefits and challenges.”
Source: ESTRO/LinkedIn
More posts by ESTRO in OncoDaily.